NewLink Genetics Newswire

NewLink Genetics Newswire

Comprehensive Real-Time News Feed for NewLink Genetics.

Results 1 - 20 of 103 in NewLink Genetics

  1. Is Potbelly Corp (PBPB) A Good Stock To Buy?Read the original story

    Yesterday | Insider Monkey

    ... than similarly priced stocks. That's why at the end of this article we will examine companies such as NewLink Genetics Corp (NASDAQ:NLNK), Versartic Inc (NASDAQ:VSAR), and Casella Waste Systems Inc. (NASDAQ:CWST) to gather more data points. At Q3's ...

    Comment?

  2. Is OMNOVA Solutions Inc. (OMN) Worthy of Your Portfolio?Read the original story w/Photo

    Sunday Dec 4 | Insider Monkey

    ... That's why at the end of this article we will examine companies such as Potbelly Corp (NASDAQ: PBPB ), NewLink Genetics Corp (NASDAQ: NLNK ), and Versartic Inc (NASDAQ: VSAR ) to gather more data points. At Insider Monkey, we've developed an ...

    Comment?

  3. The race for a Zika vaccineRead the original story

    Saturday Nov 19 | Crofs Blogs

    ... highly unusual," said Dr. Thomas P. Monath, the chief scientific officer and chief operating officer of NewLink Genetics, one of the companies developing a vaccine. "It reflects the big opportunity and public health need, and also the fact that we ...

    Comment?

  4. NewLink Genetics Corp. (NLNK) Position Reduced by Eqis Capital Management Inc.Read the original story w/Photo

    Saturday Nov 19 | Daily Political

    Eqis Capital Management Inc. lowered its stake in shares of NewLink Genetics Corp. by 3.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 46,645 shares of the company's stock after selling 1,464 shares during the period.

    Comment?

  5. Unnoticed By The Street, Roche Updated NewLink Genetics IDO Partnership At ESMORead the original story w/Photo

    Thursday Nov 17 | Seeking Alpha

    ... for huge upside with Roche's efforts into other tumor types. For those readers knowledgeable about NewLink Genetics' (NASDAQ: NLNK ) story, I am putting the link and transcript at the top of this article. For those readers wishing some background, I ...

    Comment?

  6. FY2016 Earnings Forecast for NewLink Genetics Corp. (NLNK) Issued By Jefferies GroupRead the original story w/Photo

    Nov 5, 2016 | Daily Political

    NewLink Genetics Corp. - Equities research analysts at Jefferies Group lowered their FY2016 earnings per share estimates for shares of NewLink Genetics Corp. in a research note issued to investors on Tuesday. Jefferies Group analyst B. Amin now anticipates that the firm will post earnings of per share for the year, down from their prior estimate of .

    Comment?

  7. NewLink Genetics Provides Operational Update And Reports Third Quarter 2016 Financial ResultsRead the original story

    Oct 31, 2016 | BioSpace

    NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported consolidated financial results for the third quarter of 2016 and progress in its clinical and pipeline development programs. "We continue to focus our clinical developmental efforts targeting the IDO pathway.

    Comment?

  8. NewLink Genetics Corp. (NLNK) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPSRead the original story w/Photo

    Nov 1, 2016 | Daily Political

    NewLink Genetics Corp. announced its earnings results on Tuesday. The company reported earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of by $0.06.

    Comment?

  9. NewLink Genetics Corp. (NLNK) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPSRead the original story w/Photo

    Nov 1, 2016 | AmericanBankingNews.com

    NewLink Genetics Corp. announced its earnings results on Tuesday. The company reported earnings per share for the quarter, topping analysts' consensus estimates of by $0.06.

    Comment?

  10. NewLink Genetics Corp. (NLNK) to Release Quarterly Earnings on TuesdayRead the original story w/Photo

    Oct 31, 2016 | Daily Political

    NewLink Genetics Corp. is set to issue its quarterly earnings data before the market opens on Tuesday, November 1st. Analysts expect the company to announce earnings of per share for the quarter.

    Comment?

  11. NewLink Genetics Corp. (NLNK) Earns Hold Rating from Jefferies GroupRead the original story w/Photo

    Oct 28, 2016 | AmericanBankingNews.com

    ... downside of 2.99% from the stock's current price. Separately, Zacks Investment Research raised shares of NewLink Genetics Corp. from a "hold" rating to a "buy" rating and set a $13.00 price objective on the stock in a report on Tuesday, July 5th. ...

    Comment?

  12. NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst And Investor DayRead the original story

    Oct 25, 2016 | BioSpace

    AMES, Iowa & NEW YORK, Oct. 25, 2016 -- NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today shared its strategy for becoming a leading immuno-oncology company at the company's 2016 meeting for analysts and investors in New York City. The program focused on the science and increasing validation of the IDO pathway as a target for oncology drug candidates and NewLink Genetics' clinical programs.

    Comment?

  13. NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor DayRead the original story

    Oct 25, 2016 | P&T Community

    AMES, Iowa & NEW YORK, Oct. 25, 2016 -- NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today shared its strategy for becoming a leading immuno-oncology company at the company's 2016 meeting for analysts and investors in New York City. The program focused on the science and increasing validation of the IDO pathway as a target for oncology drug candidates and NewLink Genetics' clinical programs.

    Comment?

  14. Bear Thesis on Corbus Pharma Could Cause a Crash Landing for High-Flying Biotech StockRead the original story w/Photo

    Oct 25, 2016 | TheStreet.com

    ... bear calls before in my columns. Most recently, he was short Mast Therapeutics , CytRx , Immunomedics , NewLink Genetics , Chiasma and Celldex Therapeutics before they all blew up. Now, he's short Corbus. Resunab, the only drug in Corbus' research ...

    Comment?

  15. NewLink Genetics To Host Its Third Quarter 2016 Financial Results...Read the original story

    Oct 23, 2016 | BioSpace

    NewLink Genetics Corporation , today reported that it will release its third quarter 2016 financial results on Tuesday, November 1, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results and to give an update on clinical and business development activities.

    Comment?

  16. NewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016Read the original story

    Oct 24, 2016 | P&T Community

    NewLink Genetics Corporation , today reported that it will release its third quarter 2016 financial results on Tuesday, November 1, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results and to give an update on clinical and business development activities.

    Comment?

  17. NewLink Genetics To Webcast 2016 Analyst And Investor Day On October 25, 2016Read the original story

    Oct 19, 2016 | BioSpace

    NewLink Genetics Corporation today announced that it will webcast its Analyst and Investor Day being held on Tuesday, October 25 at the Convene Meeting Center in New York City. The Analyst and Investor Day will be webcast live and a link can be accessed at edge.media-server.com/m/p/8ewqspg8 or through the NewLink Genetics website, investors.linkp.com/events.cfm , starting at 12:45 pm ET.

    Comment?

  18. NewLink Genetics Corp. (NLNK) Upgraded to Buy by Zacks Investment ResearchRead the original story w/Photo

    Oct 16, 2016 | AmericanBankingNews.com

    ... target price suggests a potential downside of 10.78% from the stock's previous close. According to Zacks, "NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic ...

    Comment?

  19. Cancer Immunotherapy ETF Celebrates One-Year AnniversaryRead the original story

    Oct 13, 2016 | BioSpace

    ... AGEN), bluebird bio (5.05 percent weighting, ticker: BLUE), Xencor (4.77 percent weighting, ticker: XNCR), Newlink Genetics (4.62 percent weighting, ticker: NLNK), Bellicum (4.44 percent weighting, ticker: BLCM), CytomX Therapeutics (4.14 percent ...

    Comment?

  20. NewLink Genetics Corp. (NASDAQ:NLNK) Given Average Recommendation of "Hold" by BrokeragesRead the original story w/Photo

    Oct 6, 2016 | AmericanBankingNews.com

    Shares of NewLink Genetics Corp. have been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the company. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have issued a buy recommendation on the company.

    Comment?